ACELYRIN, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.33 USD | +0.70% |
|
-8.46% | -41.96% |
| May. 09 | Acelyrin, Inc. Announces Ron Oyston to Step Down as Chief People Officer, Effective August 15, 2024 | CI |
| May. 09 | Acelyrin, Inc. Announces CEO Changes | CI |
Valuation
| Fiscal Period: December | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Capitalization 1 | 726.2 | 425.8 | - | - |
| Enterprise Value (EV) 1 | 726.2 | 550 | 355 | 425.8 |
| P/E ratio | -1.37 x | -2.07 x | -0.99 x | -1.03 x |
| Yield | - | - | - | - |
| Capitalization / Revenue | - | - | - | 10.2 x |
| EV / Revenue | - | - | - | 10.2 x |
| EV / EBITDA | - | -1.32 x | -0.81 x | - |
| EV / FCF | - | -1.78 x | -0.88 x | -0.91 x |
| FCF Yield | - | -56.1% | -113% | -110% |
| Price to Book | - | -1.81 x | -14.8 x | - |
| Nbr of stocks (in thousands) | 97,339 | 99,027 | - | - |
| Reference price 2 | 7.460 | 4.300 | 4.300 | 4.300 |
| Announcement Date | 3/28/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Net sales 1 | - | - | - | - | 41.86 |
| EBITDA 1 | - | - | -416.4 | -437.4 | - |
| EBIT 1 | - | -422.1 | -320.6 | -471.1 | -559.9 |
| Operating Margin | - | - | - | - | -1,337.57% |
| Earnings before Tax (EBT) 1 | - | -381.6 | -134.1 | -442.4 | -532.2 |
| Net income 1 | -64.77 | -381.6 | -134.1 | -442.4 | -532.2 |
| Net margin | - | - | - | - | -1,271.3% |
| EPS 2 | -21.09 | -5.430 | -2.080 | -4.337 | -4.186 |
| Free Cash Flow 1 | - | - | -308.5 | -401.5 | -470 |
| FCF margin | - | - | - | - | -1,122.77% |
| FCF Conversion (EBITDA) | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - |
| Announcement Date | 4/13/23 | 3/28/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | - | - | - | - | - | - | - | - | - | - |
| EBITDA 1 | - | - | - | - | -82.72 | -102.9 | -104.9 | - | - | - |
| EBIT 1 | - | -42.7 | -94.42 | -105.1 | -82.77 | -81.5 | -79.2 | -77.1 | -169.6 | -166.6 |
| Operating Margin | - | - | - | - | - | - | - | - | - | - |
| Earnings before Tax (EBT) 1 | - | -26.04 | -83.94 | -95.21 | -34.97 | -34.4 | -33 | -31.7 | -169.6 | -166.6 |
| Net income 1 | -176.4 | -26.04 | -83.94 | -95.21 | -34.97 | -34.4 | -33 | -31.7 | -169.6 | -166.6 |
| Net margin | - | - | - | - | - | - | - | - | - | - |
| EPS 2 | -8.610 | -0.4000 | -0.8700 | -0.7500 | -0.3600 | -0.3500 | -0.3300 | -0.3200 | -1.690 | -1.650 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 6/15/23 | 8/14/23 | 11/7/23 | 3/28/24 | 5/14/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Net Debt 1 | - | - | 124 | - | - |
| Net Cash position 1 | - | - | - | 70.8 | - |
| Leverage (Debt/EBITDA) | - | - | -0.2982 x | - | - |
| Free Cash Flow 1 | - | - | -309 | -402 | -470 |
| ROE (net income / shareholders' equity) | - | - | -80.9% | -207% | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - |
| Assets 1 | - | - | - | - | - |
| Book Value Per Share 2 | - | - | -2.370 | -0.2900 | - |
| Cash Flow per Share | - | - | - | - | - |
| Capex 1 | - | - | 2.5 | 2.33 | 3 |
| Capex / Sales | - | - | - | - | 7.17% |
| Announcement Date | 4/13/23 | 3/28/24 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
4.33
USD
Average target price
22.17
USD
Spread / Average Target
+411.93%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -41.96% | 426M | |
| +8.63% | 115B | |
| +13.17% | 107B | |
| -12.76% | 22.31B | |
| -3.99% | 21.6B | |
| -7.19% | 18.23B | |
| -39.93% | 17.62B | |
| +6.67% | 14.26B | |
| +33.90% | 12.37B | |
| -28.60% | 8.28B |
- Stock Market
- Equities
- SLRN Stock
- Financials Acelyrin, Inc.